Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.
about
Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell linesDeletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathwayThe peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells.Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.Anti-tumoral effects of miR-3189-3p in glioblastomaActivation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cellsPPARα modulates gene expression profiles of mitochondrial energy metabolism in oral tumorigenesisMetformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states.Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolismFenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer.Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth.Stimulating effect of normal-dosing of fibrates on cell proliferation: word of warning.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27 kip pathway in human glioblastoma cells.Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells.Novel MEK inhibitor trametinib and other retinoblastoma gene (RB)-reactivating agents enhance efficacy of 5-fluorouracil on human colon cancer cells.Differential Effects of MicroRNAs on Glioblastoma Growth and Migration.Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro.Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.Regulation of IGFBP-2 expression during fasting.FABP4 is a candidate marker of cerebellar liponeurocytomas.Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.Roles of α-linolenic acid on IGF-I secretion and GH/IGF system gene expression in porcine primary hepatocytes.Chemical modulation of autophagy as an adjunct to chemotherapy in childhood and adolescent brain tumors
P2860
Q28481551-B64C0EED-6181-4220-80C9-43D8FBFE51EEQ33492769-B2AAF4EE-691A-4BDD-987B-658456A8C137Q33589182-2541ED24-AFF0-403B-9206-2A6EE8EBF15CQ33755975-AAE999AE-203F-4E67-9BFE-FFCFB63FF62BQ33800226-17BA4896-04BE-4E81-96A7-7C73E0575EA0Q34402079-5D0A4F0B-00C3-403F-9193-52AD3DED7620Q34968487-B45C4A42-D833-430D-A4E8-3C612C120CDCQ35221508-1002D438-360C-4DD8-8ABB-E7E996DDFE03Q36318813-C8BA1F55-6629-4E2D-8CE5-E4FE1E2DAD01Q36413381-F8E56424-E697-4A90-9582-CAEEE9387DD6Q36573120-97268B89-C82D-41E4-8365-53FBB9C31392Q36724703-ED90D2C1-E6EA-4656-93CC-55226FCA1D94Q36781253-DFA8FE89-0D95-4F80-AEBB-3241B3C74CF2Q37012110-611AC298-D672-4A59-A468-82DD2DCC86BEQ37231752-882C41D5-C38D-4AA5-8E68-61A95F4D2175Q37278876-B8245163-B131-4E25-80CA-23CFA8A3B92DQ37656960-56651FAC-62BE-45CE-9D97-2B940B8CF3B4Q38883374-F460C923-9F3B-427F-85B9-5F11B94352E1Q38922376-8C761CD6-2CEB-427D-9745-7778E4EF7CEFQ38941022-B5CE571A-6148-49B1-A15C-CA58D7D2AAF7Q39189050-0B459085-A2BD-47BF-82BF-ADDA5E8BF199Q39219681-603DB420-3A2B-45AD-9269-9045DA6E462AQ39325469-2DDBB678-C4AF-4367-882E-BB11353FE480Q39689666-80809D31-44B4-4E09-BB7A-09566D6644F4Q39753305-95CF1C0A-9216-45E2-92A2-EBC3435A4A2BQ39810178-56ADC8C0-3747-4A22-87C7-AF5A00899FCBQ45281383-DBF6EB7E-CACD-45E5-A88D-2AB2CE7976D4Q50068821-78AEEDBF-22FA-4286-BF8C-212BD4C45B91Q54288268-2AFBC060-A2BE-4EEE-BB63-3737AED740A0Q59133202-889423C1-7E44-4C94-898F-9C00F4C9F5A6
P2860
Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@en
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@nl
type
label
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@en
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@nl
prefLabel
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@en
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines.
@nl
P2093
P2860
P356
P1476
Activation of PPARalpha inhibi ...... in medulloblastoma cell lines
@en
P2093
Kamel Khalili
Katarzyna Urbanska
Krzysztof Reiss
Paola Pannizzo
Sidney Croul
P2860
P304
P356
10.1002/IJC.23588
P577
2008-09-01T00:00:00Z